Questions: Myocardial Infarction and Ischemia-Reperfusion Injury

Question 1

A patient arrives in the emergency department 30 minutes after sudden-onset chest pain. Their initial troponin level is within normal limits. What is the correct clinical interpretation?

• A. Acute MI is ruled out — troponin is the gold-standard biomarker and would be elevated immediately if significant necrosis were occurring
• B. Acute MI cannot be ruled out — troponin typically rises 2–4 hours after infarct onset, so a normal value at 30 minutes is expected even with ongoing necrosis; serial troponins and ECG are required
• C. The patient likely has unstable angina without infarction, since true MI always elevates troponin within 60 minutes of coronary occlusion
• D. Normal troponin at 30 minutes confirms that any ischemia resolved before irreversible necrosis began

Answer: (B)

Troponin I and T are structural proteins bound to the cardiac contractile apparatus. When cardiomyocytes die by coagulative necrosis, these proteins must diffuse out of destroyed cells, through the interstitium, into lymphatics, and finally into the bloodstream. This process takes time — troponin typically becomes detectable 2–4 hours after infarct onset and peaks around 24 hours. A patient 30 minutes into an MI may have irreversible necrosis already underway but a completely normal initial troponin. Ruling out MI requires serial troponin measurements (at 0, 3, and 6 hours) plus clinical and ECG assessment.

Question 2

What is the primary molecular mechanism by which reperfusion of ischemic myocardium causes additional cardiomyocyte death?

• A. Re-oxygenation stops anaerobic glycolysis, suddenly depleting ATP and triggering a secondary energy crisis more severe than during ischemia
• B. Re-oxygenation generates a burst of reactive oxygen species and triggers opening of the mitochondrial permeability transition pore (mPTP), collapsing the mitochondrial membrane potential and releasing cytochrome c to initiate apoptosis
• C. Restored blood flow mechanically disrupts fragile cell membranes that were weakened by ischemic swelling, releasing DAMPs that amplify sterile inflammation
• D. Reperfusion causes coronary vasospasm that re-occludes the infarct vessel within minutes, producing a second wave of ischemia

Answer: (B)

Ischemia allows Ca²⁺ to accumulate inside mitochondria. When oxygen is suddenly restored, ischemic mitochondria resume electron transport but generate a burst of reactive oxygen species (ROS) in the process. This ROS surge, combined with high mitochondrial Ca²⁺, triggers the mitochondrial permeability transition pore (mPTP) to open irreversibly. The mPTP collapses the proton gradient across the inner mitochondrial membrane, halting ATP synthesis and causing mitochondrial swelling. Cytochrome c is released into the cytoplasm, activating the caspase cascade and apoptosis. Cells viable at the moment of reperfusion die in the subsequent hours through this mechanism.

Question 3

Restoring coronary blood flow (reperfusion) can cause death of cardiomyocytes that were still viable at the moment when flow was restored, through molecular mechanisms distinct from the original ischemic injury.

• T. True
• F. False

Answer: True

This is the ischemia-reperfusion paradox. The net effect of reperfusion is almost always beneficial — salvaging far more myocardium than it kills. But a subset of cells that survived the ischemic period — stunned but not yet dead — are then killed by reperfusion itself. The mechanisms are distinct: ischemia kills primarily through ATP depletion and calcium overload causing coagulative necrosis. Reperfusion injury kills through ROS bursts, mPTP opening, and neutrophil-mediated inflammation causing apoptosis. This is why therapeutic strategies to block mPTP opening or scavenge ROS at the time of reperfusion (reperfusion cardioprotection) are an active research area.

Question 4

Troponin begins to rise in the bloodstream within 10–15 minutes of coronary occlusion because cardiomyocyte membranes are disrupted as soon as ischemia begins.

• T. True
• F. False

Answer: False

Troponin elevation is substantially delayed despite the fact that ischemia begins immediately and irreversible necrosis starts within 20–40 minutes. The delay occurs because troponin is a structural protein physically bound to the contractile apparatus inside the myocyte. Even after membrane disruption, troponin must diffuse through the cell, cross the interstitium, enter lymphatic channels, and then reach the venous circulation before becoming measurable in a blood sample. This diffusion takes 2–4 hours. Early normal troponin does not mean the heart is not infarcting — it means the necrosis products have not yet reached the bloodstream in detectable quantities.

Question 5

Explain the ischemia-reperfusion paradox: why does restoring coronary blood flow cause additional cardiomyocyte death, and what are the key molecular mechanisms involved?

Model answer: During ischemia, Ca²⁺ accumulates in cardiomyocytes and especially in mitochondria as the Na⁺/Ca²⁺ exchanger reverses and ATP-dependent pumps fail. When blood flow is restored, re-oxygenation of calcium-loaded mitochondria generates a burst of reactive oxygen species. High mitochondrial Ca²⁺ combined with ROS triggers the mitochondrial permeability transition pore (mPTP) to open irreversibly, collapsing the proton gradient and releasing cytochrome c to activate apoptosis. Additionally, neutrophils flooding the area with reperfusion add inflammatory injury. Cells that survived the ischemic period — still viable at the moment of reperfusion — die in subsequent hours through these mechanisms.

The paradox matters clinically because it sets a ceiling on how much reperfusion can help and motivates 'cardioprotection' strategies applied at the moment of reperfusion (e.g., ischemic postconditioning, cyclosporine to block mPTP). The key concept is that the same reoxygenation that rescues ATP production also triggers a burst of ROS from electron transport chains that have built up reduced intermediates during ischemia. The mitochondria are the site of both the problem (mPTP) and the solution (ATP restoration), which is why this injury is hard to prevent without also blocking beneficial reperfusion effects.